Common Adverse drug reactions to First line drugs in Tuberculosis care and the role of m-Health in patient self-reporting and pharmacovigilance in Nigeria: A Narrative review

Common Adverse drug reactions to First line drugs in Tuberculosis care and the role of m-Health in patient self-reporting and pharmacovigilance in Nigeria: A Narrative review

The treatment of tuberculosis requires the use of First line drugs that often cause adverse drug reactions (ADR) in some patients and this is capable of affecting adherence to the treatment. Many patients do not report these ADRs even though technologies are available at their disposal. The objecti...

Full description

Bibliographic Details
Main Authors:	Edward E, Ekanem US, Ekanem AM
Format:	Article
Language:	English
Published:	Nigerian Medical Association, Akwa Ibom State Branch 2021-04-01
Series:	Ibom Medical Journal
Subjects:	Tuberculosis First line drugs Adverse drug reactions Health Patient self-reporting
Online Access:	https://ibommedicaljournal.org/index.php/imjhome/article/view/70

Similar Items

Adverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis
by: Rajendra Prasad, et al.
Published: (2021-01-01)

Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study
by: Mehari Woldemariam Merid, et al.
Published: (2019-03-01)

First-Line Anti-Tuberculosis Drug Resistance Pattern
by: Ayurveda Zaynabila Heriqbaldi, et al.
Published: (2022-01-01)

Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis
by: Madeeha Laghari, et al.
Published: (2020-01-01)

Adverse drug reactions to first-line antituberculosis drugs at four DOTS centers in Goa, India
by: Rupchandra Navelkar, et al.
Published: (2023-01-01)

Drug resistance profile of Mycobacterium tuberculosis isolates from patients referred to tuberculosis reference laboratory in Kosovo
by: Rrezarta Bajrami, et al.
Published: (2019-01-01)

Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis Therapy
by: Ausi Y, et al.
Published: (2021-11-01)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
by: Xiaofang Tan, et al.
Published: (2020-10-01)

Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022-01-01)

Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
by: Asif Massud, et al.
Published: (2022-06-01)

Analysis of adverse drug reactions reported to national pharmacovigilance center of Bhutan
by: Pelden Chejor, et al.
Published: (2021-06-01)

A 5 year retrospective analysis of pharmacovigilance study, completeness and quality of suspected adverse drug reaction forms at adverse drug reaction monitoring center Port Blair.
by: Priyanka Hotha, et al.
Published: (2021-12-01)

Pulmonary tuberculosis incidence and drug resistance-related factors analysis in North China
by: Zheng Qi, et al.
Published: (2019-01-01)

Perspective of undergraduate health-care students on adverse drug reaction and pharmacovigilance
by: Ahmed Atia, et al.
Published: (2023-01-01)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
by: Hadi MA, et al.
Published: (2017-03-01)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
by: Kishor A Bansod, et al.
Published: (2020-01-01)

Adverse drug reaction patterns of first-line anti-tubercular drugs among saharia tuberculosis patients: An observational study in particularly vulnerable tribal group of Madhya Pradesh, India
by: Prashant Mishra, et al.
Published: (2023-01-01)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
by: Maria Antonietta Barbieri, et al.
Published: (2022-02-01)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
by: Louis Létinier, et al.
Published: (2021-03-01)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
by: Hyeong-Geun Jo, et al.
Published: (2021-12-01)

Common adverse cutaneous drug reaction patterns and the causative drugs in Malaysia
by: N. H. Talib, et al.
Published: (2015-07-01)

Causality assessment, severity and preventability of adverse drug reactions due to first-line antitubercular agents
by: Gunjan Upadhyay, et al.
Published: (2022-07-01)

Incidence and Predictors of Adverse Drug Events Among People Receiving Drug Resistant Tuberculosis Treatment in Uganda: 8-Year Retrospective Cohort Study
by: Nasasira M, et al.
Published: (2022-12-01)

Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years
by: Julia E. Karrer, et al.
Published: (2019-06-01)

Ambispective study of adverse drug reactions in multi-drug resistant tuberculosis patients in Warangal, Telangana
by: Safurah Fatima, et al.
Published: (2021-01-01)

Pharmacovigilance study of spontaneous adverse drug reaction in a tertiary care centre
by: Wazid Ali, et al.
Published: (2022-01-01)

Adverse reactions among patients being treated for multi-drug resistant tuberculosis in Egypt from July 2006 to January 2009
by: Mohamed Awad Tag El-Din, et al.
Published: (2015-07-01)

A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border
by: Pola Becerril-Montes, et al.
Published: (2013-04-01)

Effect of concomitant HIV infection on adverse drug reactions by first line antitubercular drugs - a case series analysis
by: Alka Bansal, et al.
Published: (2020-10-01)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
by: Zakir Khan, M.Phil, et al.
Published: (2022-04-01)

A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases
by: Andreea C. Brabete, et al.
Published: (2022-02-01)

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
by: Francesca Filippi-Arriaga, et al.
Published: (2023-07-01)

Pharmacovigilance and incidence of adverse drug reactions in hospitalized pediatric patients: a mini systematic review
by: Zakir Khan, et al.
Published: (2020-08-01)

Medication and the Risk of Falls: An Analysis of Adverse Drug Reactions Reported to the Portuguese Pharmacovigilance System
by: Daniela Rodrigues, et al.
Published: (2023-11-01)

Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system
by: Skryabina A.A., et al.
Published: (2023-03-01)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
by: Daniele Sartori, et al.
Published: (2020-08-01)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
by: Pierre Karapetiantz, et al.
Published: (2018-05-01)

Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area
by: Cucunawangsih, et al.
Published: (2015-01-01)

Adverse drug reactions in self-medication
by: Smuseva O.N., et al.
Published: (2012-03-01)

The role of Clinical Pharmacists in the improvement of a pharmacovigilance system: A review of the reported adverse drug reactions during 2004-2010 in Mazandaran Province of Iran.
by: Ebrahim Salehifar, et al.
Published: (2015-10-01)